Skip to main content
SpringerLink
Log in

Benign Hematological Diseases in Cancer Patients

  • Reference work entry
  • First Online:
Oncologic Critical Care

Abstract

Cancer patients frequently develop hematological problems that require direct management. Understanding their pathophysiology provides one with important clinical insight that directs appropriate therapeutic interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 949.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Andersohn F, Konzen C, Garbe E. Systemic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007;146:657–65.

    Article  Google Scholar 

  2. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580–7.

    Article  Google Scholar 

  3. Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med. 2017;377:1177–87.

    Article  Google Scholar 

  4. Escobar MA. Bleeding in the patient with a malignancy: is it an acquired factor VIII inhibitor? Cancer. 2012;118:312–20. https://doi.org/10.1002/cncr.26304.

    Article  PubMed  Google Scholar 

  5. Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost. 2012;11:223–33.

    Article  Google Scholar 

  6. Garratty G, Arndt PA. An update on drug-induced immune hemolytic anemia. Immunohematology. 2007;23:105–19.

    CAS  PubMed  Google Scholar 

  7. Hod E, Schwartz J. Platelet transfusion refractoriness. Br J Haematol. 2008;142:348–60.

    Article  Google Scholar 

  8. Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP. Prevalence of neutropenia in the US population: age, sex, smoking status and ethnic differences. Ann Intern Med. 2007;146:486–92.

    Article  Google Scholar 

  9. Hsieh MM, Tisdale JF, Rodgers GP. Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy? J Clin Oncol. 2010;28:1633–7.

    Article  Google Scholar 

  10. Hunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med. 2014;370:847–59.

    Article  CAS  Google Scholar 

  11. Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. https://doi.org/10.1016/j.amjmed.2003.12.008.

  12. Laskin B, Goebel J, Davies S, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation–associated thrombotic microangiopathy. Blood. 2011;118:1452–62. https://doi.org/10.1182/blood-2011-02-321315.

    Article  CAS  PubMed  Google Scholar 

  13. Lebovic D. (2018) Anemia in Malignancy. In: Provenzano R., Lerma E., Szczech L. (eds) Management of Anemia. Springer, New York, NY.

    Google Scholar 

  14. Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018;131:845–54.

    Article  CAS  Google Scholar 

  15. Leyland-Jones B, Bondarenko I, Nemsadze G, et al. A randomized, open-label, multicenter, phase III study of Epoetin alfa versus best standard of care in anemic patients with metastatic breast cancer receiving standard chemotherapy. J Clin Oncol. 2016;34:1197–207. https://doi.org/10.1200/JCO.2015.63.5649.

    Article  CAS  PubMed  Google Scholar 

  16. Morton JM, George JN. Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer. J Oncol Pract. 2016;12:522–30.

    Article  Google Scholar 

  17. Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Blood Adv. 2017;1:2295–301.

    Article  CAS  Google Scholar 

  18. Pozo AL, Godfrey EM, Bowles KM. Splenomegaly: investigation, diagnosis and management. Blood Rev. 2009;23:105–11.

    Article  Google Scholar 

  19. Rodgers GM et al. Cancer- and chemotherapy-induced anemia. NCCN Clinical Practice Guidelines in Oncology Version 2.2018 – 11/21/2017. 2017.

    Google Scholar 

  20. Sanford RA, Kroll MH. Cancer-associated thrombosis. In: Kantarjian HM, Wolff RA, editors. The MD Anderson manual of medical oncology. 3rd ed. New York: McGraw-Hill; 2016.

    Google Scholar 

  21. Schiffer CA, Bohlke K, Delaney M, et al. Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2018;36:283–99.

    Article  Google Scholar 

  22. Smith TJ, Bohlke K, Armitage JO. Recommendations for the use of white blood cell growth factors: American Society of Clinical Oncology clinical practice guideline update. J Oncol Pract. 2015;11:511–3.

    Article  Google Scholar 

  23. Tas F, Eralp Y, Basaran M, et al. Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol. 2002;25:371–9.

    Article  Google Scholar 

  24. Varki A. Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood. 2007;110:1723–9.

    Article  CAS  Google Scholar 

  25. Gibson C, Berliner N. How we evaluate and treat neutropenia in adults. Blood. 2014;124(8):1251–8. https://doi.org/10.1182/blood-2014-02-482612.

  26. Mantha S et al. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era. Blood. 2017;129(13):1763–1767. https://doi.org/10.1182/blood-2016-10-747170.

Download references

Author information

Authors and Affiliations

  1. UT MD Anderson Cancer Center, Houston, TX, USA

    Kelly N. Casteel & Michael H. Kroll

Authors
  1. Kelly N. Casteel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael H. Kroll
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Critical Care and Respiratory Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Joseph L. Nates

  2. Division of Anesthesiology, Critical Care and Pain Medicine, Department of Critical Care and Respiratory Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Kristen J. Price

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Casteel, K.N., Kroll, M.H. (2020). Benign Hematological Diseases in Cancer Patients. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74588-6_101

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74588-6_101

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74587-9

  • Online ISBN: 978-3-319-74588-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation